Technical Analysis for HOLX - Hologic, Inc.

Grade Last Price % Change Price Change
grade A 44.12 2.37% 1.02
HOLX closed up 2.37 percent on Friday, January 18, 2019, on 1.77 times normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Earnings due: Jan 30

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical HOLX trend table...

Date Alert Name Type % Chg
Jan 18 Pocket Pivot Bullish Swing Setup 0.00%
Jan 18 Overbought Stochastic Strength 0.00%
Jan 18 Up 3 Days in a Row Strength 0.00%
Jan 18 Up 4 Days in a Row Strength 0.00%
Jan 17 Overbought Stochastic Strength 2.37%
Jan 17 Up 3 Days in a Row Strength 2.37%
Jan 16 Shooting Star Candlestick Bearish 2.68%
Jan 16 Lizard Bearish Bearish Day Trade Setup 2.68%
Jan 16 Overbought Stochastic Strength 2.68%
Jan 15 Stochastic Sell Signal Bearish 2.75%

Older signals for HOLX ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Hologic, Inc. develops, manufactures, and supplies diagnostics, medical imaging systems, and surgical products for women. The company's Breast Health segment offers full field digital mammography, C-View, screen-film mammography, computer aided detection, Trident specimen radiography, and stereotactic breast biopsy systems; healthcome mammography, breast biopsy, and breast brachytherapy products; and breast tomosynthesis, Selenia full field digital mammography platform, SecurView workstation, MammoPad breast cushions, photoconductor coatings, and Sentinelle medical MRI breast coils and workstations. Its Diagnostics segment provides APTIMA family of assays, target capture/nucleic acid extraction technology, transcription-mediated amplification technology, hybridization protection and dual kinetic assays, instrumentation, Invader chemistry platform, Cervista HPV tests, and ThinPrep system. The company's GYN Surgical segment offers NovaSure system to treat women with excessive menstrual bleeding; MyoSure system for the hysteroscopic removal of fibroids; Towerfree Hysteroscopy System for the visualization and inspection of the uterine cavity; Aquilex Fluid Control System to measure the inflow and outflow of fluid from the patient during hysteroscopic procedures; and Adiana system, a procedure for permanent female contraception. Its Skeletal Health segment provides QDR X-Ray bone densitometers that assess the bone density of fracture sites; Sahara clinical bone sonometers, which assess the bone density of heels; and Mini C-Arm imaging systems to perform minimally invasive surgical procedures on a patient's extremities. The company sells its products through direct sales and service forces, a network of independent distributors, and sales representatives primarily in the United States, Europe, and the Asia-Pacific. The company has a strategic alliance with Quest Diagnostics Incorporated. Hologic, Inc. was founded in 1985 and is headquartered in Bedford, Massachusetts.
Is HOLX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 45.17
52 Week Low 35.1
Average Volume 2,614,199
200-Day Moving Average 40.1108
50-Day Moving Average 41.6268
20-Day Moving Average 40.869
10-Day Moving Average 42.454
Average True Range 1.1218
ADX 19.64
+DI 34.0585
-DI 18.8069
Chandelier Exit (Long, 3 ATRs ) 40.7746
Chandelier Exit (Short, 3 ATRs ) 40.8454
Upper Bollinger Band 44.6949
Lower Bollinger Band 37.0431
Percent B (%b) 0.92
BandWidth 18.722748
MACD Line 0.6257
MACD Signal Line 0.1959
MACD Histogram 0.4298
Fundamentals Value
Market Cap 12.37 Billion
Num Shares 280 Million
EPS 2.68
Price-to-Earnings (P/E) Ratio 16.46
Price-to-Sales 3.49
Price-to-Book 3.63
PEG Ratio 2.06
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 45.89
Resistance 3 (R3) 45.70 44.92 45.60
Resistance 2 (R2) 44.92 44.47 45.02 45.50
Resistance 1 (R1) 44.52 44.19 44.72 44.71 45.40
Pivot Point 43.74 43.74 43.84 43.84 43.74
Support 1 (S1) 43.34 43.29 43.54 43.53 42.84
Support 2 (S2) 42.56 43.01 42.66 42.74
Support 3 (S3) 42.16 42.56 42.65
Support 4 (S4) 42.35